International Conference on Drug Development
February 27-29, 2012
Mission Statement:
To offer the most informative and up to date conference in the science and regulation of global drug development
Conference Theme:
Fostering Innovation and Translational Research in Support of Public Health and Economic Growth
Conference Subtheme:
Moving the FDA into the XXI Century - Advancing Regulatory Science into Medicines - Balancing Pharmaceutical Innovation, Drug Safety and Economic Growth
Program Overview
The International Conference on Drug Development (ICD2), formerly known as the International Industrial Pharmacy Conference (IIPC) continues its 52nd year tradition of offering an informal forum for the exchange of ideas concerning the drug discovery and drug development process. This conference has been referred to as the Gordon Conference on Drug Development and is proudly presented by The University of Texas at Austin College of Pharmacy. The conference is known for bringing together national and international scientists from academia, the pharmaceutical industry, the biotechnology industry and regulatory agencies for the opportunity to learn of and discuss new initiatives for finding a better way to develop new drugs and improve the quality of existing drug products. Ample time is provided for questions and discussion, to expand upon particular points of interest throughout the conference. The conference concludes Wednesday evening with the FDA panel discussion, which provides conference participants the opportunity to direct questions and comments to the panel of FDA members for thought and discussion.
Conference Goal
The goal of ICD2 is to update participants on the national and international initiatives affecting the development of safe and effective pharmaceutical drug products. By the end of the program, the attendee will develop an appreciation and in-depth understanding of the continuous scientific and regulatory efforts to improve the quality of pharmaceutical products and their impact on pharmaceutical care.
Contact Information
Mailing Address:
The University of Texas
at Austin
College of Pharmacy
Continuing Educaton
1 University Station,
A1904
Austin, TX
78712-0123
USA
Email Address: UTPharmacyCE
@austin.utexas.edu
Phone:
1-512-471-6213
Fax:
1-512-475-9739
Past participant comments:
"Always advances my understanding in a topic area.
A conference I don't like to miss."
Janet Woodock, M.D.
Director, Center for Drug Evaluation & Research, FDA
Food and Drug Administration
"What distinguishes this meeting from others I attend is the designed opportunity to interact with my peers in the industry and the FDA is an
informal
setting."
Gerald Yakatan, Ph.D.
Founder & Chairman
IriSys, Inc.
"This meeting is a great opportunity for industry and agency leadership to address impediments to drug development."
Keith O. Webber, Ph.D.
Deputy Director, Office of Pharmaceutical Science
Center for Drug Evaluation & Research, FDA
